Your browser doesn't support javascript.
loading
Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
Han, Jing; Chen, Congcong; Wang, Cheng; Qin, Na; Huang, Mingtao; Ma, Zijian; Zhu, Meng; Dai, Juncheng; Jiang, Yue; Ma, Hongxia; Jin, Guangfu; Shen, Hongbing; Hu, Zhibin.
Afiliação
  • Han J; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Chen C; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Wang C; Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
  • Qin N; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Huang M; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Ma Z; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhu M; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Dai J; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Jiang Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Ma H; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Jin G; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Shen H; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Hu Z; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Liver Int ; 40(9): 2117-2127, 2020 09.
Article em En | MEDLINE | ID: mdl-32574393
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article